The FDA on Paxlovid and COVID-19: What physicians need to know, Part II episode artwork

EPISODE · Feb 15, 2022 · 14 MIN

The FDA on Paxlovid and COVID-19: What physicians need to know, Part II

from AMA Update · host American Medical Association

In part two of this three-part series, Stephanie Troy, MD, senior medical officer, Division of Antivirals, Office of Infectious Disease in the Center for Drug Evaluation and Research’s Office of New Drugs, FDA, discusses what to know about Paxlovid as treatment for COVID-19.

Episode metadata supplied by the publisher feed · Published Feb 15, 2022

Embed this episode

NOW PLAYING

The FDA on Paxlovid and COVID-19: What physicians need to know, Part II

0:00 14:49

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of AMA Update?

This episode is 14 minutes long.

When was this AMA Update episode published?

This episode was published on February 15, 2022.

Can I download this AMA Update episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!